BACKGROUND: Studies have shown a mismatch between published cancer screening and genetic counseling referral recommendations and physicianreported screening and referral practices. Inaccurate cancer risk assessment is one potential cause of this mismatch. OBJECTIVE: To assess U.S. physicians' ability to accurately determine a woman's colon and ovarian cancer risk level. DESIGN, PARTICIPANTS: Cross-sectional survey of U.S. family physicians, general internists, and obstetrician-gynecologists. A twelve-page questionnaire with a vignette of a woman's annual examination included a question about the patient's level of colon and ovarian cancer risk. The final study sample included 1,555 physicians weighted to represent practicing U.S. physicians nationally. MAIN MEASURE: Accuracy of physicians' ovarian and colon cancer risk assessments. KEY RESULTS: Overall, most physicians accurately assessed women's risk of ovarian (57.0 %, CI 54.3, 59.6) and colon cancer (62.0 %, CI 59.4, 64.6). However, 27.1 % (CI 23.0, 31.6) of physicians overestimated the ovarian cancer risk among women at the same risk as the general population, and 65.1 % (CI 60.2, 69.7) underestimated ovarian cancer risk among women at much higher risk than the general population. Physicians overestimated colon more than ovarian cancer risk (38.0 %, CI 35.4, 40.6 vs. 27.1 %, CI 23.0, 31.6) for women at the same risk as the general population. CONCLUSIONS: Physicians' misestimation of patient ovarian and colon cancer risk may put average risk patients in jeopardy of unnecessary screening and higher risk patients in jeopardy of missed opportunities for prevention or early detection of cancers.
INTRODUCTION
The development of evidence-based recommendations for both cancer screening and genetic counseling and testing for cancer risk holds promise for the prevention and early detection of many cancers. [1] [2] [3] The US Preventive Services Task Force (USPSTF) has published and widely disseminated independent, rigorous evaluations of the evidence and the balance of the benefits and harms of preventive services, including cancer screening. 4 Yet appropriate application of these recommendations is complex. Health care providers first must gather the information needed for risk assessment, including family and personal history of cancer, and demographics (e.g., age, ethnicity), then estimate the patient's cancer risk. Based on this estimated risk, physicians can discuss and educate their patients about the risks and benefits of screening, and genetic counseling and testing if indicated, then conduct or refer for appropriate testing and/or counseling. Physicians report that when patients expect to have cancer screening tests or are anxious about cancer, they order these tests more often. 5 Accurate risk assessment is important so that women at average cancer risk undergo routine cancer screening only, and not unnecessary testing (e.g., more frequent colorectal cancer screening, genetic counseling), and so that women at higher than average cancer risk do not forego testing (e.g., genetic counseling, testing) that can prevent cancers. Until now, much of the published literature on cancer risk assessment and its application in practice has focused on physician elicitation of family history data, and their referral patterns for genetic counseling and testing for cancers with available genetic marker testing (e.g., breast, colon). [6] [7] [8] [9] [10] [11] This research has demonstrated that providers do not consistently gather enough family history information to Electronic supplementary material The online version of this article (doi:10.1007/s11606-014-2768-2) contains supplementary material, which is available to authorized users.
adequately assess risk, 6, 7, [11] [12] [13] [14] [15] and that patients, who frequently underestimate or overestimate their cancer risk, [16] [17] [18] may not accurately report family history of cancer. 19 Primary care providers, while interested in playing a role in genetic counseling and testing, are not necessarily knowledgeable about hereditary cancers, [20] [21] [22] and do not necessarily make effective use of available family history. 23 Studies have shown mismatch between published recommendations and reported referral for genetic counseling and testing, [24] [25] [26] as well as mismatch between recommendations against routine ovarian cancer screening and physician reported screening practices. 27 Further research is needed to understand the reasons for these mismatches-whether providers are inaccurately assessing patients' cancer risks, are unaware of the indications for routine screening or genetic counseling and testing, or disagree with published recommendations.
This study helps fill one of these research gaps by using the results of the Women's Health Survey of family physicians, general internists, and obstetriciangynecologists to answer the question: To what degree do U.S. physicians accurately categorize ovarian and colon cancer risk based on a patient's family and personal cancer history and demographic data? We hypothesized that physicians would frequently miscategorize patient cancer risk, given prior research showing that physicians report screening women at average risk for ovarian cancer, and that women with family or personal histories suggestive of BRCA 1/2 risk are often not referred for genetic counseling or testing.
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METHODS
Study Survey and Design
The Women's Health Survey, conducted in fall 2008, was a cross-sectional survey of 3,200 family physicians, general internists, and obstetrician-gynecologists randomly sampled equally from the American Medical Association (AMA) Physician Masterfile. The AMA Physician Masterfile maintains demographic, contact, and education, training and professional certification information on virtually all U.S. Doctors of Medicine (MD) and Doctors of Osteopathic Medicine (DO). 31 The sampled physicians were ages 64 years and younger, and practiced in office or hospital-based settings. With a response rate of 61.7 %, and after exclusions, the study population included 1,555 physicians who completed training (i.e., residency, fellowship) and provided women's outpatient care. A full description of the survey methods (a modified Tailored Design Method 32 ) have been published elsewhere. 27 This research study was approved by ). In all vignettes, the woman's colon cancer risk was the same as the general population, because no vignette included a family or personal history of conditions that routinely increase colon cancer risk or suggest that a physician should deviate from the USPSTF average-risk screening recommendations (e.g., hereditary colon cancer syndromes, personal history of colorectal cancer or adenomas, personal history of inflammatory bowel disease). 2 Physicians were asked to provide their best estimate of the woman's risk level for colon and ovarian cancer compared to the general population-the same as, somewhat higher than, or much higher. The questionnaire also elicited physician demographics, practice characteristics, attitudes towards risk, beliefs about cancer screening tests, sources of information about cancer screening, and non-professional cancer experience (Appendix 1, available online).
Study Variables
Outcome Variables. Each physician received a vignette representing a woman in one of three ovarian cancer risk groups, depending on her reported family and personal history of cancer: much higher, somewhat higher, or the same as the general population. All vignettes portrayed women at the same colon cancer risk as the general population. We created variables that reflected study physicians' accuracy of estimating ovarian and colon cancer risk by identifying whether the physicians overestimated, underestimated, or correctly estimated the woman's level of ovarian cancer risk, and overestimated or correctly estimated her colon cancer risk.
Covariates. Patient Characteristics. Patient characteristics were varied in the vignette (see Study Survey and Design), and included age, race, insurance type, and request for ovarian cancer screening.
Physician Characteristics. Physician characteristics included factors that might influence their cancer screening intentions-belief about the clinical effectiveness of cancer screening tests (4-point Likert scale from strongly agree to strongly disagree), measures of attitude toward risk-taking and malpractice concern (7-point and 5-point Likert scales, respectively, from strongly agree to strongly disagree, based on original research that developed these measures), 38, 39 and whether physicians listed the U.S. Preventive Services Task Force (USPSTF), the American College of Obstetrics and Gynecology (ACOG), the National Institutes of Health (NIH)/National Cancer Institute (NCI), or the American Cancer Society (ACS) within the top three organizations influencing their cancer screening recommendations (chosen from nine organizations relevant to the specialties surveyed, and a write-in option). We also included physician practice factors that might inhibit or support screening-geographic location (urban, large rural, or small/isolated small rural area [based on Rural Urban Commuting Area codes linked by physician ZIP code]) 40, 41 ; census division; primary practice setting (e.g., office practice, community health center); group/ solo practice type; involvement in clinical teaching; average number of outpatients seen weekly; and board certification. Last, we measured other physician characteristics associated with cancer screening (i.e., age, sex, years in practice, specialty), and that we hypothesized might be associated with cancer risk estimation (i.e., non-professional cancer experience: none, with a family member/close friend/co-worker only, the physician's own cancer experience).
We compared respondents and non-respondents on variables available through the AMA Physician Masterfile (physician specialty, sex, age, and present employment), and found differences only by "present employment" type (for respondents and non-respondents: group practice 69.3 % versus 63.6 %, self-employed 17.7 % versus 22.2 %, government 6.9 % versus 7.0 %, and other 6.1 % versus 7.2 %, respectively, P=0.02).
Analysis
We used SUDAAN 10.0 (RTI International, Research Triangle Park, NC) to weight the responses of family physicians, general internists, and obstetrician-gynecologists to their representative number in the practicing U.S. physician population using AMA Physician Masterfile counts. We examined the rate at which physicians overestimated, underestimated, or accurately estimated the ovarian cancer risk of women at the three levels of true ovarian cancer risk, and overestimated or accurately estimated the colon cancer risk of the women, all of whom had the same risk as the general population. We compared the percentage of over, under, and accurate risk assessment by patient, physician, and practice characteristics for ovarian and colon cancer, using P≤0.01 to denote significance due to multiple comparisons. Stepwise multivariate logistic regression analysis identified the physician and practice characteristics independently, and significantly associated with overestimating or underestimating risk at the P≤0.05 level after controlling for all patient characteristics. Physician and practice characteristics that were significantly associated in unadjusted analysis with overestimating or underestimating risk at the P≤0.05 level were investigated for possible inclusion in the stepwise regression models. Because accurately estimating risk is a common outcome, we calculated risk ratios within SUDAAN based on predicted marginals. 42 
RESULTS
Characteristics of the Physician Study Sample
Our study sample included 41.8 % family physicians, 40.8 % general internists, and 17.4 % obstetrician-gynecologists (Table 1) . Nearly half had been in practice over 20 years. Almost one-fourth were in solo practice. Over half (53.5 %) listed the USPSTF, 33.6 % NIH/NCI, 65.6 % ACS, and 31.1 % ACOG as one of the top three organizations influencing their cancer screening recommendations.
Ovarian Cancer Risk Assessment
Overall, 57.0 % of physicians correctly estimated the ovarian cancer risk of the woman portrayed in the vignette. However, there was substantial mismatch between physicians' estimates of cancer risk and patients' true cancer risk (Table 2 ). Over one-quarter (27.1 %) of physicians overestimated the ovarian cancer risk of a woman with the same risk level as the general population; 65.1 % underestimated the ovarian cancer risk of a woman with much higher risk than the general population. For the vignettes depicting women at somewhat higher risk of ovarian cancer, physicians were over four times more likely to overestimate (32.3 %) than underestimate (7.3 %) ovarian cancer risk.
Accuracy of ovarian cancer risk estimation was largely consistent across patient and physician characteristics ( 
DISCUSSION
In this vignette-based survey, the majority of physicians accurately assessed women's risk of ovarian (56.9 %) and colon cancer (62.0 %). Notably, however, sizeable proportions of physicians overestimated and underestimated ovarian cancer risk and overestimated colon cancer risk. Several patient and physician characteristics were significantly associated with individual measures of overestimation or underestimation of cancer risk in our adjusted analyses, but there were no consistent findings across our measured outcomes.
The few studies that have examined physicians' ability to assess patients' cancer risks 25, [28] [29] [30] found similar misestimation rates. Physicians have demonstrated particular difficulty with accurately judging the cancer risk of individuals with more than one or two relatives with a relevant cancer. 30 This is consistent with our finding that a powerful predictor of overestimating colon cancer was the patient's personal history of breast cancer, even though there is no clear evidence that this increases a woman's colon cancer risk. 43 Both overestimating and underestimating cancer risk has important clinical implications. Overestimating cancer risk can lead to overuse of screening and genetic testing. Routine screening of women at average risk for ovarian cancer with CA-125 or transvaginal ultrasound is not recommended. 44 These tests have high false positive and low positive predictive values for average risk women, 45, 46 and do not improve ovarian cancer's morbidity and mortality. [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] Contrary to recommendations, sizeable proportions of physicians have reported offering ovarian cancer screening to average risk women, and physician estimation that a woman was at Results were adjusted using weights to represent the specialty distribution of the practicing U.S. physician population CI confidence interval a
The percentages reported do not sum to 100 % due to data rounding higher risk of ovarian cancer than the general population was one of the most powerful predictors of this finding. 27 Likewise, 28.7 % of physicians have reported recommending genetic counseling or BRCA1/2 testing for women who were not at high ovarian cancer risk, and their estimation of a woman's ovarian cancer risk was the most powerful predictor of this recommendation. 26 Overestimating colon cancer risk also could lead to overscreening. Many primary care providers reported recommending colorectal cancer screening at younger ages and at more frequent intervals than evidence-based guidelines indicate. 63 Overscreening related to overestimating colon cancer risk increases patient risks from tests and procedures, decreases capacity to screen individuals who meet evidence-based eligibility guidelines, and increases health care costs.
The underestimation of ovarian cancer risk found in this study is also problematic. Individuals with family histories suggesting a high risk of ovarian and breast cancers are more likely to have BRCA1/2 genetic mutations, and prophylactic surgery can prevent these cancers. 64 This study suggests that nationally, physicians underestimate ovarian cancer risk for roughly two-thirds of these women. Prior research has found that among women at high ovarian cancer risk, physicians who underestimated a woman's risk as the same as the general population reported referring or testing only 5.4 % of them, whereas physicians who accurately assessed women as high risk reported referring or testing 64.6 % of them. 26 Other studies have demonstrated that women at high risk of ovarian and breast cancer are not routinely offered the opportunity to This study's results are limited by its survey methods. The survey results may not generalize to non-respondents, though this survey had a high response rate, 61.7 %, and the respondents and non-respondents were comparable on most measured variables. We assessed the women's true cancer risks based only on family and personal history presented in the hypothetical vignette. Physicians in practice are able to elicit a more complete picture of patients and their health, which could influence risk assessment. Our prior research has shown that risk estimation is a powerful predictor of physician-reported cancer screening and referral for genetic counseling or testing; 26, 27 additional research is needed to corroborate this with actual test ordering and referrals. Several variables that define overestimation and underestimation of cancer risk combine different degrees of misestimation. For example, physicians who overestimated ovarian cancer risk among women at the same risk as the general population either estimated their risk as somewhat or much higher. Our sample size does not allow us to differentiate these two types of risk overestimation. Additionally, the cancer risk estimation scale was one-sided, only including risk categories that were higher than the general population, which may have encouraged participants to overestimate cancer risk.
Additional limitations include this study's focus on women's health. We only surveyed physician specialties that provide primary care to women. It is possible that gastroenterologists would have been less likely to overestimate colon cancer risk. Also, our survey was conducted in 2008, and high profile news stories (e.g., Angelina Jolie) 67 may have increased patient and physician awareness of cancer risks, potentially increasing the accuracy of physician risk assessment. We did not include the National Comprehensive Cancer Network (NCCN) on the list of organizations that may have influenced physicians' cancer screening recommendations, because we surveyed only women's primary care providers. Thus the survey may have missed noting the NCCN as an influential organization. Finally, there are no clear definitions of "acceptable" cancer risk misestimation in the literature. The rates found in this study are clearly not ideal, but further work is needed to identify an attainable target for accuracy of cancer risk assessment.
A substantial proportion of physicians nationally may be inaccurately estimating ovarian and colon cancer risk, putting average risk patients in jeopardy of unnecessary screening and misdirection of health care resources, and higher risk patients in jeopardy of missed opportunities for prevention or early detection of cancers. Improving cancer risk assessment among U.S. health care providers will require a concerted national effort, and is important for accurate screening and appropriate use of the growing number of genetic tests. 68 This study's results offer a first step by informing training programs, professional organizations, and government agencies about the deficits in cancer risk assessment among physicians. The increasing use of electronic health records provides new, innovative opportunities for identifying at-risk patients, given the structured format in which age and family history can be entered into the record. Future research is needed to explore use of electronic health records for assessing individual patients' cancer risk and for notifying providers at a patient visit about evidence-based guidelines tailored to this risk. 
